Pie Medical Imaging: Pie Medical Imaging Announces FASTIII, a Multicenter Randomized Clinical Trial

The FAST III study aims to demonstrate non-inferiority of CAAS vFFR guided revascularization as compared to a conventional invasive wire based FFR guided revascularization in patients with either stable coronary syndrome or non-ST segment elevation myocardial infarction and intermediate coronary artery lesions. The post Pie Medical Imaging Announces FASTIII, a Multicenter Randomized Clinical Trial appeared first on Medical Device News Magazine.